Health
Experts warn weight‑loss drug rush could jeopardise insulin supply
The Guardian reported that a surge in GLP‑1 weight‑loss drugs may threaten the availability of insulin, a core treatment for diabetes.
Topic
Eli Lilly’s Mounjaro
1 story
Topic
1 story
The Guardian reported that a surge in GLP‑1 weight‑loss drugs may threaten the availability of insulin, a core treatment for diabetes.